Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders

Psychiatry Research

Volumn 153, Issue 1, 2007, Pages 83-86

  Pae, Chi Un ^a,b   Yoon, Soo Jung ^c   Patkar, Ashwin A ^b   Kim, Jung Jin ^a   Lee, Chul ^a   Paik, In Ho ^a  

^a The Catholic University of Korea   (South Korea)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c The Catholic University of Korea   (South Korea)

Author keywords

Mood disorder; NQO1 gene; Polymorphism

Indexed keywords

DNA; GENE PRODUCT; OXIDOREDUCTASE; PROTEIN NQ01 C609T; QUINONE OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DETOXIFICATION; DISEASE PREDISPOSITION; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; NQ01 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC;

EID: 34548500771     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2006.01.011     Document Type: Article

References (11)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. (1994), American Psychiatric Press, Washington, DC
2. 609C → T polymorphism with a decreased lung cancer risk. Cancer Research 59 (1999) 3045-3048
3. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV-Clinician Version (SCID-CV) (1997), American Psychiatric Press, Washington, DC
4. Jaiswal A.K., Bell D.W., Radjendirane V., and Testa J.R. Localization of human NQO1 gene to chromosome 16q22 and NQO2-6p25 and associated polymorphisms. Pharmacogenetics 9 (1999) 413-418
5. Kappus H., and Sies H. Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 37 (1981) 1233-1241
6. Liou Y.J., Wang Y.C., Lin C.C., Bai Y.M., Lai I.C., Liao D.L., and Chen J.Y. Association analysis of NAD(P)H[ratio]quinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan. International Journal of Neuropsychopharmacology 8 (2005) 483-486
7. Pae C.U., Yu H.S., Kim J.J., Lee C.U., Lee S.J., Jun T.Y., Lee C., and Paik I.H. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia. International Journal of Neuropsychopharmacology 7 (2004) 495-500
8. Park N., Juo S.H., Cheng R., Liu J., Loth J.E., Lilliston B., Nee J., Grunn A., Kanyas K., Lerer B., Endicott J., Gilliam T.C., and Baron M. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Molecular Psychiatry 9 (2004) 1091-1109
9. Siegel D., McGuinness S.M., Winski S.L., and Ross D. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase I. Pharmacogenetics 9 (1999) 113-121
10. Traver R.D., Horikoshi T., Danenberg K.D., Stadlbauer T.H., Danenberg P.V., Ross D., and Gibson N.W. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Research 52 (1992) 797-802
11. Traver R.D., Siegel D., Beall H.D., Phillips R.M., Gibson N.W., Franklin W.A., and Ross D. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). British Journal of Cancer 75 (1997) 69-75